Inventor · disambiguated record
Yongkai Chen
Also filed as: CHEN YONGKAI
13 granted patents·21 pending applications·7 citations·filing 2017–2023
83Inventor score
Files withWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD22SHANGHAI MEIYUE BIOTECH DEV CO LTD7WUHAN CREATERNA SCIENCE AND TECH CO LTD5
Top patents by PatentIndex Score
34 records- 0179US10611757B2Crystalline form of chemical compound, and preparation method, composition, and application thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2017·Granted Apr 7, 2020·2 cites·20 claims
- 0276US11008311B2Potassium salt of benzimidazole compound and preparation method therefor, composition and application thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2017·Granted May 18, 2021·2 cites·12 claims
- 0375US11013736B2Oral solid preparation and use thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2017·Granted May 25, 2021·2 cites·14 claims
- 0469US11040958B2Triazole antimicrobial derivative, pharmaceutical composition and use thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2018·Granted Jun 22, 2021·1 cites·15 claims
- 0561US2025074908A1Salt of rock inhibitor, crystal form of salt, composition, and pharmaceutical useWUHAN CREATERNA SCIENCE AND TECH CO LTD·Filed 2023·Application pending·0 cites
- 0658US12503444B2Compound containing benzene ring and application thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2020·Granted Dec 23, 2025·0 cites·10 claims
- 0758US2025082655A1Use of heterocyclic compoundWUHAN CREATERNA SCIENCE AND TECH CO LTD·Filed 2023·Application pending·0 cites
- 0857US2024293420A1Pharmaceutical composition, preparation, and preparation method therefor and use thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2022·Application pending·0 cites
- 0957US2025197414A1Salt form and crystal form of vanin enzyme inhibitor, method for preparing same, and use thereofSHANGHAI MEIYUE BIOTECH DEV CO LTD·Filed 2023·Application pending·0 cites
- 1056US12377083B2Lysophosphatidic acid receptor antagonist and preparation method thereforWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2020·Granted Aug 5, 2025·0 cites·3 claims
- 1156US2024391877A1Compound as inhibitor of complement factor d, and pharmaceutical composition and use thereofWUHAN CREATERNA SCIENCE AND TECH CO LTD·Filed 2022·Application pending·0 cites
- 1256US2024239735A1Acid addition salt of rock inhibitor, and crystal form, composition and pharmaceutical use thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2022·Application pending·0 cites
- 1355US2025171414A1Compound serving as masp-2 inhibitor, pharmaceutical composition, preparation method therefor, and use thereofWUHAN CREATERNA SCIENCE AND TECH CO LTD·Filed 2023·Application pending·0 cites
- 1454US2025161283A1Use of indazole compound for treating psoriasisWUHAN CREATERNA SCIENCE AND TECH CO LTD·Filed 2023·Application pending·0 cites
- 1553US2024317755A1Heterocyclic compound, and intermediate thereof, preparation method therefor and use thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2022·Application pending·0 cites
- 1652US12503468B2Heterocyclic compound, intermediate, preparation method therefor and application thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2019·Granted Dec 23, 2025·0 cites·22 claims
- 1752US2023257382A1Heterocyclic compound and use thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2021·Application pending·0 cites
- 1851US2023257376A1Rock inhibitor, and preparation method therefor and use thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2021·Application pending·0 cites
- 1951US2024182443A1Polymorphic forms of compound and preparation method therefor and application thereofSHANGHAI MEIYUE BIOTECH DEV CO LTD·Filed 2022·Application pending·0 cites
- 2051US2023406850A1Crystalline form of heterocyclic compound, preparation method therefor and application thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2021·Application pending·0 cites
- 2150US12378204B2Triazole compounds and preparation method therefor and use thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2020·Granted Aug 5, 2025·0 cites·8 claims
- 2249US2024124479A1Pyrimidine carboxamide compound and use thereofSHANGHAI MEIYUE BIOTECH DEV CO LTD·Filed 2021·Application pending·0 cites
- 2348US11337972B2Pharmaceutical preparation and use thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2019·Granted May 24, 2022·0 cites·11 claims
- 2448US2023331710A1Heterocyclic compound, preparation method and use thereofSHANGHAI MEIYUE BIOTECH DEV CO LTD·Filed 2021·Application pending·0 cites
- 2548US2024083873A1Pyrimidine carboxamide compound and application thereofSHANGHAI MEIYUE BIOTECH DEV CO LTD·Filed 2021·Application pending·0 cites
- 2648US2023250064A1Preparation method for fused pyrazole-type compoundSHANGHAI MEIYUE BIOTECH DEV CO LTD·Filed 2021·Application pending·0 cites
- 2748US2023286947A1Complement factor b inhibitor, and pharmaceutical composition, preparation method and use thereofSHANGHAI MEIYUE BIOTECH DEV CO LTD·Filed 2021·Application pending·0 cites
- 2848US2023118751A1Fused ring compound and application thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2020·Application pending·0 cites
- 2947US11161803B2Ammonium carboxylate compound, crystalline form, amorphous form and preparation method thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2018·Granted Nov 2, 2021·0 cites·21 claims
- 3047US2023050653A1Rock inhibitor and preparation method therefor and use thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2020·Application pending·0 cites
- 3145US2023104283A1Jnk inhibitor, and pharmaceutical composition and use thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2020·Application pending·0 cites
- 3239US11096928B2Pharmaceutical compositionWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2017·Granted Aug 24, 2021·0 cites·13 claims
- 3338US11786471B2Complex disintegrant system for oral solid preparation and oral solid preparation comprising said complex disintegrant systemWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2017·Granted Oct 17, 2023·0 cites·13 claims
- 3434US10517867B2Posaconazole derivative, pharmaceutical composition and use thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2017·Granted Dec 31, 2019·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Yongkai Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →